MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Out-licensing

Fast Electron Paramagnetic Resonance Imaging (EPRI) Using CW-EPR Spectrometer with Sinusoidal Rapid-Scan and Digital Signal Processing

National Institutes of Health (NIH)
These improvements to CW-EPR will allow changes of blood perfusion and oxygenation in tumors to be observed in nearly real-time, while improved resolution will permit angiogenesis in and around tumors to be carried out in a non-invasive manner.

Full description

Electron Paramagnetic Resonance (EPR) Imaging is an indispensable tool that may be applied to a variety of disciplines for evaluation of chemical species having unpaired electrons such as free radicals and transition metal ions.  In Continuous Wave (CW)-EPR the sample is continuously irradiated with weak RF radiation while sweeping the magnetic field relatively slowly.  Existing CW-EPR techniques utilize a signal detection method known as phase-sensitive detection which results in data acquisition times that are too long for in vivo applications.  The present technology represents significant improvements on conventional CW-EPR. 

The subject technology includes three approaches to collecting image data with increased spatial, temporal and spectral resolution and improved sensitivity.  Spectral data acquisition is performed by a direct detection strategy involving mixing a signal to base-band and acquiring data with a fast-digitizer.  Projection data is acquired using a sinusoidal magnetic field sweep under gradient magnetic fields.  Data collection times are decreased with the utility of rotating gradients.  Further, the current technology improves sensitivity by employing Digital Signal Processing, which decreases background analog noise.

Increased speed and sensitivity makes CW-EPR a potentially useful and complementary tool to Magnetic Resonance Imaging for in vivo imaging.  The presently described improvements to CW-EPR will allow changes of blood perfusion and oxygenation in tumors to be observed in nearly real-time, while improved resolution will permit angiogenesis in and around tumors to be carried out in a non-invasive manner.  Additionally, rapid scan imaging provides excellent temporal resolution and will help quantify pharmaco-kinetics and metabolic degradation kinetics of bioactive free radicals.

Applications:

·  Enhanced spatial, temporal, and spectral resolution of Continuous Wave-Electron Paramagnetic Resonance Imaging

·  Real-time assessment of changes in blood perfusion and oxygenation

Development Status: 

Preliminary experiments have been conducted and the technology has been tested for feasibility.

Publication:

S Subramanian, JW Koscielniak, N Devasahayam, RH Pursley,  TJ Pohida, TJ Pohida, MC Krishna. A new strategy for fast radiofrequency CW EPR imaging: direct detection with rapid scan and rotating gradients.  J Magn Reson. 2007 Jun;186(2):212-219. [PubMed abs]

Patent information

Patent Status: 

U.S. Provisional Application No. 60/818,052 filed 30 Jun 2006 (HHS Reference No. E-221-2005/0-US-01)

PCT Application No. PCT/US2007/00072371 filed 02 Jul 2007 (HHS Reference No. E-221-12005/0-PCT-02)

 

Inventors: 

Sankaran Subramanian, Nallathamby Devasahayam, Janusz Koscielniak, James Mitchell, and Murali Krishna (NCI)

 

Type of business relationship sought

Licensees Sought: 

Available for non-exclusive or exclusive licensing and commercial development.

Collaborative Research Opportunity: 

The Radiation Biology Branch, National Cancer Institute, NIH, Bethesda, MD is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the above Rapid scan-Rotating gradients strategy for performing routine in vivo Radiofrequency CW EPR imaging in small animals.  Please contact John D. Hewes, Ph.D. at 301-435-3121 or hewesj@mail.nih.gov for more information.

Licensing contact

Rung C Tang
Licensing and Patenting Manager
Office of Technology Transfer

Contact directly

Company details

National Institutes of Health (NIH)

The NIH supports and conducts basic, clinical, and translational medical research, and investigates the causes, treatments, and cures for both common and rare diseases.

View profile

Related reports

Are you looking for reports related to this particular subject. Our Reports section is the best place to start.

Related categories

Clients in focus...

Get the Flash Player to see this rotator.

Partnering and licensing intelligence in life sciences industry
GenericsWeb
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us